The outcomes of the needed postapproval confirmatory PROLONG trial produced conflicting results, stopping working to reveal a benefit of 17 OHP on either preterm birth or neonatal result. Medscape Medical News
Learn More
- Mon. Dec 23rd, 2024
Latest News